Esophageal Carcinosarcoma: Clinical Characteristics and Prognostic Factors

Esophageal carcinosarcoma is a rare malignancy characterised by the coexistence of epithelial carcinoma and mesenchymal sarcoma components within the same tumour. Clinically, it often presents with dysphagia, weight loss and retrosternal discomfort, and is frequently detected as a polypoid or ulcerated mass on endoscopic examination. Imaging studies reveal variable patterns of local invasion and lymph node enlargement, while histopathology confirms a biphasic architecture with both squamous or glandular carcinoma elements and spindle-cell sarcomatous areas. Prognostic factors include tumour size, depth of invasion, lymph node status and patient age. Early-stage lesions treated with surgical resection and extended lymphadenectomy demonstrate improved survival, whereas advanced cases with nodal or distant spread carry a poorer prognosis. Molecular profiling has begun to reveal recurrent TP53 mutations, alterations in receptor tyrosine kinases and activation of downstream RAS/PI3K pathways, suggesting potential avenues for targeted therapy. Immunohistochemical markers such as cytokeratins and vimentin assist in defining the dual nature of the tumour and may guide diagnostic accuracy. Collectively, these characteristics underpin a multidisciplinary approach combining surgery, chemotherapy and emerging molecular treatments to optimise outcomes.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Esophageal Carcinosarcoma: Clinical Characteristics and Prognostic Factors publication trend

The graph below shows the total number of articles in esophageal carcinosarcoma: clinical characteristics and prognostic factors across all publications each year (not limited to Nature Index journals).

Technical terms

Carcinosarcoma: A tumour containing both malignant epithelial (carcinomatous) and mesenchymal (sarcomatous) elements.

Neoadjuvant chemotherapy: Drug treatment administered before surgical resection to reduce tumour burden.

Thoracoscopic oesophagectomy: Minimally invasive surgical removal of the oesophagus performed via small chest incisions.

Receptor tyrosine kinase (RTK): A class of cell-surface receptors that regulate growth and survival signals and may be altered in cancer.

Immunohistochemistry: Laboratory technique using antibodies to detect specific proteins in tissue sections, aiding in tumour characterisation.

References

1. Preoperative chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for locally advanced esophageal carcinosarcoma: a case report and review of the literature. Surgical Case Reports (2018).
2. Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma. BMC Cancer (2018).
3. The alterations of cytokeratin and vimentin protein expressions in primary esophageal spindle cell carcinoma. BMC Cancer (2018).